Simvastatin Completed Phase 2 Trials for Portal Hypertension / Liver Cirrhosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00594191Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension